About us

We are working to change the future of rapid point-of-care diagnostics

We specialize in development of ultrasensitive and rapid point-of-care diagnostics. We strongly believe in bringing doagnostic testing closer to the patient, both human and animals. Our objective is to increase sensitivity of immunoassys to the level allowing for majority of the tests to migrate to a true Point-of-Care format.

Company mission

A spectrum of Biopromic’s proprietary technologies allows us to develop simple -to -use and affordable tests for clinical and veterinarian settings.

We specialize in production of ultra-sensitive monoclonal antibodies targeted primarily against carbohydrate antigens derived from bacteria and viruses. We also produce a wide range of bacterial antigens and their analogs.